Historical salary details - Mr. Daniel Tasse, Lead Independent Director, Regenxbio Inc
Mr. Daniel Tasse is the Lead Independent Director of Regenxbio Inc.
Mr. Daniel Tasse
Lead Independent Director
$ 347.5 K
Gross Remuneration
-
Current Company
Regenxbio Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Regenxbio Inc | Lead Independent Director | 347.5 K | - |
| 2023 | Regenxbio Inc | Independent Director | - | - |
| 2022 | Regenxbio Inc | Independent Director | 332.9 K | 31.3 % |
| 2021 | Regenxbio Inc | Independent Director | 253.4 K | -8.4 % |
| 2021 | Indivior Plc | Non-Executive Director,Senior Independent Director | 52.9 K | -79.4 % |
| 2020 | Regenxbio Inc | Independent Director | 276.8 K | -12.2 % |
| 2020 | Indivior Plc | Non-Executive Director,Senior Independent Director | 256.2 K | 76.6 % |
| 2019 | Regenxbio Inc | Independent Director | 315.3 K | -27.6 % |
| 2019 | Indivior Plc | Non-Executive Director,Senior Independent Director | 145.1 K | 5.8 % |
| 2019 | Bellerophon Therapeutics Inc | Independent Director | - | - |
| 2018 | Regenxbio Inc | Independent Director | 435.6 K | 125.4 % |
| 2018 | Indivior Plc | Non-Executive Director | 137.1 K | 44.3 % |
| 2018 | Bellerophon Therapeutics Inc | Independent Director | 95 K | 118.9 % |
| 2017 | Regenxbio Inc | Independent Director | 193.3 K | -9.9 % |
| 2017 | Indivior Plc | Non-Executive Director | 95 K | 20.6 % |
| 2017 | Bellerophon Therapeutics Inc | Director | 43.4 K | -7.8 % |
| 2016 | Regenxbio Inc | Independent Director | 214.4 K | - |
| 2016 | Indivior Plc | Non-Executive Director | 78.8 K | 5.1 % |
| 2016 | Bellerophon Therapeutics Inc | Director | 47.1 K | 59.5 % |
| 2015 | Indivior Plc | Non-Executive Director | 75 K | 539.4 % |
| 2015 | Bellerophon Therapeutics Inc | Director | 29.5 K | - |
| 2014 | Indivior Plc | Non-Executive Director | 11.7 K | - |
| 2014 | Bellerophon Therapeutics Inc | Director | - | - |